Introduction {#sec1}
============

Autoacting or self-regulatory molecular networks provide higher level control over many complex systems of diverse disciplines, including biology, economics, and engineering.^[@ref1]^ Various complex biological processes, including pattern formation, limb development, and circadian clocks, are controlled by the interaction between pathway elements via feedback loops, maintaining homeostasis at every level from molecular biology of the cell to ecology.^[@ref2]−[@ref5]^ Amplification of the signal or self-inhibition is maintained by self-acting elements mainly either by autoactivation through a positive loop or by product inhibition via a negative loop, respectively. Recently, this higher order control behavior has also been explored/mimicked in nonbiological systems. In the late 20th century, pioneering works on template-assisted self-replication with artificial replicants were reported.^[@ref6]−[@ref8]^ The first asymmetric autocatalysis was achieved when a chiral product acted as a chiral catalyst to make more of itself, and still many more autocatalytic molecular systems are being reported.^[@ref9],[@ref10]^ Raymo reported autocatalytic fluorescence photoactivation based on product amplification through energy-transfer-dependent photochemical generation of anthracene derivatives.^[@ref11]^ The Aprahamian group reported a communicating molecular system in which a Zn^2+^-dependent hydrazone switch is regulated by a negative feedback loop; the loop is initiated when Zn^2+^-mediated release of a proton from the switch results in the formation of an imine, which sequesters Zn^2+^, thereby inhibiting the switch.^[@ref12]^ Feedback-dependent control over catalytic activity or amplification of the signal is also reported by several groups.^[@ref13],[@ref14]^ In biology, the activity of enzymes is usually finely tuned by means of feedback regulation, which enables a communication among the state of the cell, concentration of the product, etc.^[@ref1]^ Likely, control of activity by means of self-acting systems would enable selective and efficient therapies, and this potential is yet to be explored. Once optimized, such a therapeutic system would enable communication with the disease state and allow autocontrol over therapeutic activity.

Here, we report a photodynamic therapy (PDT) agent whose activity is regulated through a negative feedback loop ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). PDT is an oxygen- and light-dependent noninvasive method mainly used to treat surface tumors and certain skin diseases.^[@ref15]^ To improve the selectivity of the therapy various activatable photosensitizers (PSs) are reported.^[@ref16]−[@ref22]^ Activity control in these literature examples is maintained by inducing disease-specific chemical and/or physical transformation on the PS. pH-, glutathione-, and enzyme-mediated conversions are the most widely used methods to change the PS from an inactive to an active state. To the best of our knowledge, so far, a PS with an autocontrol behavior has not been investigated. In this study, singlet oxygen (^1^O~2~) produced by a photosensitizer acts back on the PS through a H~2~O~2~ intermediate, to reduce the efficiency of PDT action ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Mechanism of Self-Inhibitory Feedback Control over PS. **BOD1** Generates ^1^O~2~ upon Irradiation. ^1^O~2~ Is Converted into H~2~O~2~ through Reaction with Ascorbate\
H~2~O~2~ oxidizes boronate and spontaneous 1,4-elimination produces inactive **BOD2**](ao-2019-01410f_0007){#sch1}

To incorporate autoinhibition, H~2~O~2~-responsive BODIPY, **BOD1**, is used ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). **BOD1** bears a boronic ester in the structure, which is known to be oxidized by H~2~O~2~.^[@ref23]^ 1,4-Elimination on alkoxy methyl phenol follows spontaneously to generate pyridine BODIPY from a pyridinium precursor. This behavior is used to develop H~2~O~2~ sensors by others, since fluorescence is enhanced as pyridinium with charge transfer properties is transformed into pyridine.^[@ref24]^ In this work, **BOD1** is used as a PS. PDT action is mediated by ^1^O~2~, which can only be generated when energy transfer to O~2~ takes place following an intersystem crossing (ISC). Spin-forbidden ISC is either facilitated by a heavy atom or special orientation of the PSs.^[@ref25],[@ref26]^ Ziessel et al. reported that halogen-free pyridinium BODIPYs also display high ISC through the charge transfer state.^[@ref27]^ Despite this finding, heavy-atom-free pyridinium BODIPYs have not been used as PSs to date. Here, **BOD1** with similar features is used for this purpose. Pyridine BODIPY lacking charge transfer character is not expected to display efficient ^1^O~2~ generation. Based on this knowledge, we create a loop that generates **BOD2** (inefficient PS) from **BOD1** (active PS) through PDT activity of **BOD1**. Reactions involved in the loop are as follows: ^1^O~2~ generated by **BOD1** reacts with ascorbate to generate H~2~O~2~.^[@ref28]^ H~2~O~2~ then reacts with boronate and ineffective **BOD2** is produced as an end product ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Ascorbate, which is found in every cell, is chosen to be an intermediate loop element to enable communication between PS activity and the cell.

Results and Discussion {#sec2}
======================

**BOD1** and **BOD2** are synthesized as described in the literature.^[@ref24]^ Loop end product **BOD2** is proposed to be less active, and it has been claimed that it can be generated by the PDT action of **BOD1**. To compare the PDT activities of these two compounds, relative ^1^O~2~ generation efficiencies are analyzed using the ^1^O~2~ trap molecule, 1,3-diphenylisobenzofuran (DPBF). The absorbance of DPBF is known to decrease as a result of the reaction of furan with ^1^O~2~.^[@ref29]^ A comparison of the change in DPBF absorption in the presence of **BOD1** and **BOD2** indicates that the latter has significantly lower activity, consistent with the design ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). None of the compounds produces ^1^O~2~ in the dark.

![Relative ^1^O~2~ generation by **BOD1** and **BOD2** (10 μM, in isopropanol) followed by a change in the absorption of DPBF (50 μM). Samples are kept in the dark for 15 min and illuminated by 506 nm LED light for 80 min. Red: DPBF; blue: DPBF in the presence of **BOD2**; green: DPBF in the presence of **BOD1**.](ao-2019-01410f_0001){#fig1}

In the design, product inhibition is expected to be mediated by the reaction of the PDT product (^1^O~2~) with ascorbate and this reaction generates H~2~O~2~. Selective reaction of **BOD1** with peroxide produces fluorescent **BOD2**.^[@ref24]^ Thus, feedback loop analysis is performed by following changes in the fluorescence of **BOD1** in the presence or absence of ascorbate ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). Fluorescence is expected to increase as **BOD2** is produced. For this to take place, ^1^O~2~ must react with ascorbate to generate H~2~O~2~ ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Fluorescence increase in the presence of ascorbate (blue) is significantly higher than that in the control lacking ascorbate (red). This result indicates that ascorbate is needed to generate **BOD2**.

![Change in fluorescence intensity at 515 nm as **BOD1** (10 μM, in isopropanol) is converted into **BOD2**. In the presence of sodium ascorbate and light, a loop is initiated, and H~2~O~2~ is generated ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Due to H~2~O~2~-dependent degradation of the boronate moiety on **BOD1**, fluorescent **BOD2** is generated. The change in fluorescence intensity is more pronounced in the presence of sodium ascorbate. Samples are irradiated with a 506 nm LED lamp.](ao-2019-01410f_0002){#fig2}

Fluorescence quantum yields are calculated to be 0.04 and 0.31 for **BOD1** and **BOD2**, respectively ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). Consistently, upon irradiation in the presence of ascorbate, the quantum yield of **BOD1** is increased to 0.16, approaching the value for **BOD2**.

We hypothesize that due to reactions given in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}, ^1^O~2~ generation efficiency is expected to decrease in the presence of ascorbate. Consistently, the decrease in the absorption of DPBF becomes less pronounced in the presence of increasing amounts of ascorbate (0, 0.2, and 1 mM, [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).

![^1^O~2~ generation by **BOD1** (10 μM, in isopropanol) in the presence or absence of sodium ascorbate (0.2 mM shown in blue or 1 mM shown in purple) as followed by the change in the absorption of DPBF (50 μM) at 411 nm. The sample lacking sodium ascorbate (red) produces more ^1^O~2~ and DPBF alone does not decompose under experimental conditions (green). Samples are kept in the dark for the first 30 min and then irradiated with 506 nm LED light for 110 min.](ao-2019-01410f_0003){#fig3}

This can be a result of a combinatorial effect: one reason being direct scavenging of ^1^O~2~ by ascorbate and the second one is conversion of **BOD1** to a less efficient PS. [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} supports this hypothesis, showing that the change in the absorption of DPBF upon irradiation decreases in the presence of ascorbate. As shown in [Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf), during the PDT activity, the absorbance of **BOD1** at 510 nm is shown to decrease and the absorbance at 505 nm is elevated. The new peak at 505 nm overlaps with **BOD2** absorbance, supporting the formation of this molecule by PDT.

As mentioned above, one reason for the ascorbate-dependent decrease during PDT shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"} can be scavenging, namely, ascorbate may react and remove ^1^O~2~. To show that the decrease in ^1^O~2~ generation by **BOD1** in the presence of various amounts of ascorbate results mainly from conversion to **BOD2** rather than removal of ^1^O~2~, a control experiment was done. **BOD2** which lacks a peroxide-sensitive group is used as the PS and ^1^O~2~ generation efficiencies are analyzed in the presence and absence of ascorbate ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). It has been shown that when **BOD2** is used as the photosensitizer, the change in the absorption of DPBF does not display a significant variation upon use of ascorbate. This clearly indicates that removal of ^1^O~2~ from the solution by reaction with ascorbate has a minimal effect on the observed data shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. Since ^1^O~2~ is catalytically produced by the PS, this effect is negligible. Instead, quenching of the ^1^O~2~ producer (PS) through loop control seems to be the major regulator of PDT activity.

Fluorescence enhancement and spectral shift in absorption during PDT action of **BOD1** give clues about **BOD1-**to-**BOD2** conversion ([Figures [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} and [S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). To further demonstrate that **BOD2** is generated via PDT activity, the ^1^H NMR spectrum of **BOD1** is analyzed before and after irradiation in the presence of ascorbate ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). When the sample is irradiated for 80 min, **BOD2** peaks resonating at 8.73, 7.44, and 6.22 ppm appear in the spectrum. Disappearance of **BOD1** signals indicates that it is converted completely to either an intermediate oxidation product or **BOD2**. Calculations of the ratio of **BOD2** peak integrals to other peaks indicate 32% conversion to **BOD2**. Considering the duration of PDT application (usually 1 or more hours), the product ratio within a given time is acceptable. Other oxidation products and 4-hydroxybenzyl alcohol are also produced consistent with the literature.^[@ref24]^ High-resolution ESI-MS (HRMS) spectra of the samples after PDT assay show that **BOD2** is generated in ascorbate-containing experiments ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). When the sample is extracted with chloroform after analysis, ^1^H NMR shows that the only compound remaining in the organic phase is **BOD2** ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)), showing that PDT-dependent reactions do not produce a significant amount of (if any) byproducts soluble in organic solvents. NMR analysis is performed in dimethyl sulfoxide instead of isopropanol due to poor solubilities of ascorbate and PS in the latter solvent at high concentrations.

![^1^H NMR spectra (400 MHz, DMSO-*d*~6~) of **BOD1** (25 mM) (a) alone and (b) in the presence of saturated sodium ascorbate and light. (a) Upon irradiation with 506 nm light for 80 min, peaks of **BOD2** appear. (c) ^1^H NMR spectrum of **BOD2**. Structures of products are given on the top of the spectra.](ao-2019-01410f_0004){#fig4}

Although **BOD1** is soluble in aqueous media in micromolar concentrations, in situ PDT experiments are performed in isopropanol due to the lack of solubility of **BOD2** and DPBF in water. To check degradation-dependent fluorescence enhancement, a stability analysis is performed in neutral and slightly acidic buffer. Over 24 h, no significant fluorescence enhancement of **BOD1** is observed, indicating **BOD1** is stable over the experimental time scale ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). Selective oxidation of boronic ester bearing compounds (including **BOD1**) by H~2~O~2~ is reported by independent groups.^[@ref23],[@ref24],[@ref30],[@ref31]^ To demonstrate that the loop requires H~2~O~2~, ^1^O~2~-mediated conversion to **BOD2** is analyzed by ^1^H NMR in the presence of a H~2~O~2~ scavenger, sodium pyruvate.^[@ref32],[@ref33]^ Even though the reaction mixture contains ascorbate, photoconversion to **BOD2** failed, indicating the necessity of H~2~O~2~ for PS inactivation ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)).

Cationic **BOD1** (with IC~50~ of 69 μM) localizes in the mitochondria of DLD-1 ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a).(33) Mitochondrial targeting is an advantage for PDT, since in cancer tissues (to which this therapy is applied most), the oxygen level is much less than that in healthy tissues.^[@ref34]^ On the other hand, PDT requires O~2~. Indeed, targeting oxygen-rich organelle of hypoxic cancer tissue is reported to enhance PDT action.^[@ref35]^

![(a) Fluorescent micrograft of BOD1-introduced DLD-1 cells. Cells are treated with 10 μM H~2~O~2~ prior to addition of BOD1 to observe fluorescence. Cells are stained with MitoTracker Red. (b) BOD1 or BOD2 (10 μM) is introduced into DLD-1 cells. After irradiation with a 506 nm LED for 2 h, cell viability is determined by Alamar Blue.](ao-2019-01410f_0005){#fig5}

In this work, **BOD2** is produced by loop reactions and proposed to be less efficient. To demonstrate the relative PDT actions of photosensitizers in cell culture, they are introduced into DLD-1 cells ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b). Cell viability assay indicates that neither of the compounds has dark toxicity. However, upon irradiation, viability drops down to 20% with **BOD1**. **BOD2** has no significant cytotoxicity, consistent with the proposed design. That is, **BOD1** is inactivated when it is converted into **BOD2**. Results of cell culture experiments indicate that within 2 h significant cell death is induced ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}) and, at the same time, within this time scale, the photosensitizer is converted to inactive fluorescent **BOD2** ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)).

To understand the activity-reporting property of **BOD1** and photogeneration of **BOD2**, cells are exposed to 506 nm light for 6 h. Although initially there is no fluorescence, in 1 h, fluorescence is enhanced significantly ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). Within 6 h, fluorescence starts to decrease slightly which would be due to leakage of uncharged **BOD2** from the cell. Fluorescence increase within the first hours of irradiation is attributed to the formation of **BOD2**. Control samples kept in the dark for 6 h do not show any fluorescence, which supports the hypothesis that photogenerated H~2~O~2~ (not cellular peroxide) leads to the formation of fluorescent **BOD2**. Together with the relative PDT activities of **BOD1** and **BOD2**, photo-autoinactivation of **BOD1** under cellular conditions is evident ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} and [S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). In addition, since fluorescence enhancement is a result of PDT action, it allows monitoring PS activity.

Conclusions {#sec3}
===========

In conclusion, a halogen-free PS is shown to be self-inhibited. ^1^O~2~ generated by the PS is converted into H~2~O~2~, which in turn reacts with the PS and decreases the PDT activity. Fluorescence, UV--vis absorption spectra, ^1^H NMR analysis, and HRMS results prove the formation of **BOD2** in the presence of ascorbate and light. **BOD2** is shown to be less effective at inducing apoptosis in cells. Fluorescence enhancement, as **BOD1** is converted into **BOD2**, can be observed in the cell ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)). It is demonstrated that H~2~O~2~ generated through PDT (not cellular peroxide) produces **BOD2**. The proposed feedback loop control is shown in [Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}. Since the boronate group of BOD1 selectively reacts with hydrogen peroxide and cellular peroxide is not sufficient to react with this group, the results suggest that the activity can be autocontrolled via the proposed steps in vivo.

![(a) Schematic representation of autoinhibition and activity reporting. Initially (*t* \< 1 h), **BOD1** efficiently produces ^1^O~2~ and induces cell death. With time (*t* \>1 h), fluorescent and inactive **BOD2** is generated, enabling silencing of the PDT action and activity reporting. (b) Proposed mechanism of negative feedback loop initiated by and acting on the photosensitizer, **BOD1**, (i) ^1^O~2~ is generated upon irradiation; (ii) ^1^O~2~ induces cell death, at the same time, some of the ^1^O~2~ reacts with cellular ascorbate to generate H~2~O~2~; (iii) H~2~O~2~ oxidizes **BOD1**, produces fluorescent **BOD2**, and, as a result, decreases PDT efficiency. In the end of the cycle, the PDT activity of **BOD1** is inhibited as it is converted into **BOD2**.](ao-2019-01410f_0006){#fig6}

Taking the behavior of **BOD1** into account, this PS can also be considered as a self-activity reporter, namely, it reports its own PDT activity by producing fluorescent output upon singlet oxygen generation.^[@ref36]−[@ref38]^

Ascorbate, being an important element of cellular redox metabolism, enables communication of the PS with the cell and enables autoinhibition of the PS by reacting with the cytotoxic ^1^O~2~. Since inactivation is dependent on the PDT activity of the PS, the inhibitory effect of ascorbate is also highly dependent on the therapeutic activity. In other words, when ^1^O~2~ is produced to activate cell death, an autoinactivation pathway is initiated in parallel ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}).

Even though PDT activity is controlled in many different ways, to the best of our knowledge, no one has yet reported PS activity regulation by such a feedback loop.^[@ref16]−[@ref22],[@ref39]^ This behavior can be used in actual applications such that, once a certain amount of ^1^O~2~ is generated sufficiently to kill cancer cells, PS activity can be self-inhibited to diminish any further effect on neighboring healthy cells. This would improve the noninvasiveness of PDT. Activity-dependent inactivation, like we present here, would be a strategy to enable communication with the stage of therapy. With similar self-inhibitory PSs having reversible conversion between active/inactive states, an oscillatory activity can, in principle, be obtained. This behavior may find application in certain therapies, i.e., those requiring periodic drug release. This work may encourage the research in such directions.

Experimental Section {#sec4}
====================

General Methods {#sec4.1}
---------------

All reagents and solvents were purchased from commercial sources and used without further purification. Compounds **BOD1** and **BOD2** were prepared using the literature procedures.^[@ref24],[@ref27]^ Column chromatography was carried out using a silica stationary phase (230--400 mesh, SiliCycle Inc., Canada). Analytical thin layer chromatography was performed on 0.25 mm thick precoated silica gel plates (60F254, Merck, Germany). Compounds were visualized under UV light. All ^1^H NMR spectra were recorded on a Varian Inova instrument (400 MHz) at Selçuk University, Konya. Chemical shifts (δ) are reported in parts per million (ppm) and referenced to the residual solvent peak. Coupling constants (*J*) are reported in hertz (Hz). Standard abbreviations indicating multiplicities are given: br = broad, d = doublet, m = multiplet, s = singlet, and t = triplet. High-resolution mass spectrometry was carried out using an Agilent 6530 Accurate-Mass Q-TOF LC/MS of the Eastern Anatolia Advanced Technology Research and Application Centre (DAYTAM, Erzurum, Turkey). For PDT, an LED from Bright LED Electronics Corp., model BL-BG43V4V, with peak absorption value at 506 nm was used as a light source. For cell culture experiments DLD-1 human colorectal adenocarcinoma cells (ATCC) were used.

Singlet Oxygen Generation Experiments {#sec4.2}
-------------------------------------

Singlet Oxygen generations were analyzed using the singlet oxygen trap molecule, 1,3-diphenylisobenzofurane. Absorption of this molecule decreased upon reaction with ^1^O~2~. Typically, 50 μM of this compound in isopropanol was used in the presence of the photosensitizer (1, 5, or 10 μM of **BOD1** or **BOD2**). The absorption spectrum was recorded in the dark (for either 15 or 30 min). Then, samples were irradiated with a 506 nm LED lamp (Bright LED Electronics Corp., model BL-BG43V4V) from a distance of 20 cm. For samples that involve sodium ascorbate, a stock solution of this compound was prepared and added to the reaction cuvette so that the final ascorbate concentration was 0.2 or 1 mM.

^1^H NMR spectra during PDT action were recorded to determine the generation of **BOD2** in the presence of ascorbate. This experiment was performed in deuterated dimethyl sulfoxide (DMSO-*d*) instead of isopropanol because of the poor solubilities of ascorbate and photosensitizers in isopropanol at high concentrations. A saturated solution of sodium ascorbate (having concentration less than 100 mM) in DMSO-*d* was prepared. **BOD1** (25 mM) in the presence of saturated sodium ascorbate (less than 100 mM) was irradiated for 80 min with the 506 nm LED lamp. After the experiment, the sample was extracted with water and dichloromethane. The organic phase was collected and dried over sodium sulfate. The ^1^H NMR spectrum of the organic phase contained peaks corresponding to only **BOD2** ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)).

To show that hydrogen peroxide was involved in the reaction series leading to **BOD2** formation, an experiment involving a hydrogen peroxide scavenger was designed. Sodium pyruvate (NaPyr) was used as the scavenger.^[@ref32]^**BOD1** (25 mM) in the presence of saturated sodium ascorbate and sodium pyruvate (each less than 100 mM) was irradiated for 80 min with the 506 nm LED lamp and ^1^H NMR was recorded. The presence of NaPyr inhibited the formation of **BOD2** ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01410/suppl_file/ao9b01410_si_001.pdf)).

UV--Vis Absorption, Fluorescence Experiments, and Quantum Yield Calculations {#sec4.3}
----------------------------------------------------------------------------

UV--vis absorption spectra of 10 μM **BOD1** in the presence of ascorbate (0.2 mM) in isopropanol were recorded using a Cary-60 UV-Vis Spectrometer. Samples were irradiated with the 506 nm LED lamp from 20 cm for 140 min until no further shift in the spectrum was observed.

Fluorescence spectra were recorded using an Agilent, Cary Eclipse fluorescence spectrometer with a xenon flash lamp. Briefly, 10 μM **BOD1** samples in the presence or absence of 0.2 mM sodium ascorbate were prepared in isopropanol. Samples were irradiated with the 506 nm LED lamp from 20 cm for 200 min. Fluorescence spectra were recorded in 10 min intervals with excitation at 475 nm.

Quantum yields were determined using Rhodamine 6G as a reference fluorophore. Samples were excited at 488 nm. Rhodamine 6G was dissolved in water, whereas all other samples were dissolved in isopropanol. Absorbance values of the samples were kept below 0.1, to avoid an inner filter effect. Calculations were done using the following formulawhere *Q*~R~ is the quantum yield of the reference compound, *I* and *I*~R~ are the integrated areas of the emission spectrum of the sample and reference, respectively, *A* and *A*~R~ refer to the absorbance values of the sample and reference at excitation wavelength (488 nm), respectively, *n* and *n*~R~ are the refractive indices of solvents (1.333 for water and 1.3776 for isopropanol).^[@ref40]^

Cell Culture Experiments {#sec4.4}
------------------------

DLD-1 human colorectal adenocarcinoma cells (ATCC) were cultured in T-75 culture flasks in RPMI 1640 culture medium at 37 °C in a humidified incubator containing 5% CO~2~ (Binder CB Series CO~2~ incubators). The standard RPMI medium was supplemented with heat-inactivated 10% fetal bovine serum, 2 mM [l]{.smallcaps}-glutamine, 100 units mL^--1^ Penicillin G, and 100 μg mL^--1^ streptomycin at 37 °C in a humidified incubator containing 5% CO~2~. After incubation of the cell line for 24 h, the medium was washed with PBS buffer, and cell viability was tested for the 0--200 μM concentration range of **BOD1** in a 24-well plate containing 10^6^ cells/well.

To determine cellular localization, cells were treated with 10 μM H~2~O~2~ (to obtain a fluorescence image), then the medium was washed with PBS buffer. Cells were stained with MitoTracker (ThermoFisher) and after washing with PBS, 5 μM **BOD1** was introduced.^[@ref41]^ After incubation with **BOD1**, cells were washed with PBS buffer and visualized with a fluorescence microscope at 20× and 80× (Thermo Muliskan Go).

To determine cell viability in the dark and after irradiation, standard Alamar Blue (ThermoFisher) assay was performed. After incubation of cells, the medium was renewed with 10 μM of either **BOD1** or **BOD2** and irradiated with the 506 nm LED array for 2 h. Cell viability was determined using Alamar Blue assay.^[@ref42]^

To determine fluorescence enhancement due to the formation of **BOD2**, cells were incubated with 10 μM of **BOD1** and either irradiated with the 506 nm LED array for 6 h or kept in the dark (control). Fluorescence of the cells were visualized with a fluorescence microscope at 20× and 80× (Thermo Muliskan Go).

Synthesis {#sec4.5}
---------

Synthesis was performed using modified literature procedures.^[@ref24],[@ref27]^

### Synthesis of **BOD2** {#sec4.5.1}

Dichloromethane (150 mL) was purged with N~2~ for 30 min. 4-Pyridinecarboxyaldehyde (12.7 mmol, 1.36 g, 1.2 mL) was mixed with 2,4-dimethylpyyrole (26.2 mmol, 2.5 g, 2.6 mL) in degased dichloromethane. Three drops of trifluoroacetic acid (TFA) were added, and the color of the solution turned red. The solution was stirred at room temperature for 16 h under an inert atmosphere. *p*-Chloranil (6.9 mmol, 1.7 g) was added to the solution, and the solution was stirred for additional 2.5 h, followed by the addition of triethylamine (7.5 mL) and a boron trifluoride--diethyl ether complex (7.5 mL). The mixture was stirred for additional 2.5 h at room temperature. The reaction mixture was extracted with water and dichloromethane. The organic layer was collected, dried with sodium sulfate, and dichloromethane was evaporated in vacuo. The crude product was purified by silica gel column chromatography using 5% methanol in dichloromethane as the eluent. The fraction containing **BOD2** was collected, and then the solvent was evaporated under reduced pressure. The product was obtained as glitter red powder (2.5 mmol, 823 mg, 20%).

^1^H NMR (400 MHz, chloroform-*d*) δ 8.78 (d, *J* = 5.9 Hz, 2H), 7.33 (d, *J* = 6.0 Hz, 2H), 6.00 (s, 2H), 2.55 (s, 6H), 1.40 (s, 6H). High-resolution ESI-MS values are 326.1640 for theoretical *m*/*z* of (M + H)^+^ and 326.1679 for experimental (Δ: 12 ppm).

### Synthesis of **BOD1** {#sec4.5.2}

4-(4,4,5,5,-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl bromide (0.16 mmol, 47 mg) and **BOD2** (0.10 mmol, 34 mg) were dissolved in 10 mL of toluene and then the solution was refluxed at 90 °C for 16 h. After cooling, the desired product was obtained by filtering the precipitate. The red--orange solid was further washed with toluene to afford pure **BOD1** (0.05 mmol, 30.8 mg, 49.5%).

^1^H NMR (400 MHz, DMSO-*d*~6~) δ 9.39 (d, *J* = 5.9 Hz, 2H), 8.47 (d, *J* = 6.0 Hz, 2H), 7.72 (d, *J* = 7.5 Hz, 2H), 7.47 (d, *J* = 7.4 Hz, 2H), 6.26 (s, 2H), 6.00 (s, 2H), 1.35 (s, 6H), 1.33--1.19 (s, 12H). High-resolution ESI-MS values are 542.2962 for theoretical *m*/*z* of (M)^+^ and 542.2961 for experimental (Δ: 0.18 ppm).
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